Xu Lin

2.0k citations
81 papers · 1.6k indexed · h-index 25

Impact in

  • Hepatology top 5%
    • Hepatitis C virus research
    • MicroRNA in disease regulation
    • Cancer-related molecular mechanisms research

Papers in

    • Hepatitis C virus research 12
    • Hepatitis B Virus Studies 28
    • Liver Disease Diagnosis and Treatment 16

Xu Lin

78 papers receiving 1.6k citations

Peers

Xu Lin
Comparison fields: 5 of 102
  • Hepatology 286
  • Cancer Research 295
  • Epidemiology 552
  • Molecular Biology 798
  • Clinical Biochemistry 71
Replace Eiji Kakazu with:
Eiji Kakazu Japan
Zongguo Yang China
Carmine Mancone Italy
Takanori Sakaguchi Japan
Sami Siraj Pakistan
Xiaomei Wang China
Alla Arzumanyan United States
Alexander V. Bocharov United States
Osamu Koiwai Japan
Hans Jörg Hacker Germany
Xu Lin relative to Eiji Kakazu Japan Eiji Kakazu's profile →
Citations per field
00.5×
Eiji Kakazu · 1×
Citations per year

Countries citing papers authored by Xu Lin

Since Specialization
Citations

This map shows the geographic impact of Xu Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Lin more than expected).

Fields of papers citing papers by Xu Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xu Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Lin. The network helps show where Xu Lin may publish in the future.

Co-authors

The 25 scholars most cited alongside Xu Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xu Lin Line = papers co-authored together Xu Lin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202010
2 201923
3 201827
4 201825
5 201717
6 20161
7 201516
8 201515
9 201331
10 201118
11 201122
12 201134
13 201011
14 201013
15 20107
16 201011
17 200946
18
Meta-analysis of case-control studies on the dual infection of hepatitis B and C virus in carcinogenesis of hepatocellular carcinoma in China
20081
19 200843
20 200827

About Xu Lin

Xu Lin is a scholar working on Hepatology, Epidemiology, Cancer Research, Aging and Molecular Biology, having authored 81 papers that have together received 1.6k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (28 papers), Liver Disease Diagnosis and Treatment (16 papers), Hepatitis C virus research (12 papers), Ubiquitin and proteasome pathways (6 papers), Endoplasmic Reticulum Stress and Disease (5 papers), NF-κB Signaling Pathways (5 papers), Peroxisome Proliferator-Activated Receptors (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). The work is most often cited by research in Hepatology (286 citations), Cancer Research (295 citations), Epidemiology (552 citations), Molecular Biology (798 citations) and Clinical Biochemistry (71 citations). Xu Lin has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Wannan Chen, Yunli Wu, Jianyin Lin, Xinjian Lin, Wansong Lin, Xian‐E Peng, Qingling Huang, Qiaojia Huang, Lu Cai and Yu‐Mei Wen. Their work appears in journals such as Journal of Virology, Journal of Medical Virology, Oncotarget, Journal of Cancer Research and Clinical Oncology and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026